Ukrainian President Volodymyr Zelenskyy told Le Monde that Russian forces are suffering 30,000 to 35,000 casualties per month, underscoring the scale of current fighting. In the Zelenskyy interview, ...

Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & ...

Pfizer's per-share profit in 2025 declined as the company incurred significant impairment charges. The company also paid out more in dividends than it generated in free cash flow. Question marks about ...

Oscar Health (OSCR) rose 9.6% despite -$1.24 EPS miss, guiding $750M earnings improvement in 2026 with medical loss ratio dropping to 82.4%-83.4% from Q4’s 95.4%. Membership hit 3.4M. CVS Health (CVS) ...

Good day, ladies and gentlemen, and welcome to the Miller Industries Fourth Quarter 2025 Results Conference Call. Please note, this event is being recorded. And now at this time, I would like to turn ...

Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep ...

In 2024, rebates increased significantly to $1.64 billion, benefiting 8.6 million customers, equating to approximately $192 per beneficiary. For 2024, Alabama led the country with nearly $182 million ...

Bitcoin BTC $76,386.34 is down sharply as trading in the new week begins, down 5% over the past 24 hours to $64,700. U.S. stock index futures are down as well, led by the Nasdaq 100's 0.9% decline.

There is a federal law — 18 U.S.C. § 922(g)(3) — making it illegal for “unlawful users” of controlled substances or drug addicts to ship, transport, possess, or receive firearms or ammunition. ATF ...

As we close the door on 2025, it’s hard to ignore a simple truth: The U.S. healthcare system is under more strain than at any point in recent memory. But that strain didn’t appear overnight. It has ...

People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...